Syntax Bio
syntax-bio.com
Actively hiring
Regenerative Medicine
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Series A
Jun 2026 · 3 mo ago
Team
51-200
employees, estimated range
Backers
1
Illumina Ventures
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 23
Partnership Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation · YahooFinance
Jun 21
Raised a round Series A · YahooFinance
Jun 9
Partnership Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes · AOL.com
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Jun 2026 | — | — | YahooFinance |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
Cellusion develops regenerative medicine therapies using induced pluripotent stem (iPS) cells focused on treating corneal endothelial…
Juvena Therapeutics is a clinical-stage biotechnology company engineering proteins that human stem cells naturally secrete into…
Cellino is a Massachusetts biotechnology company founded in 2017. It automates stem cell manufacturing with laser editing, imaging and…
Invest on Wefunder ABOUT HEPATX STRATEGY TEAM CAREERS SCIENCE MEDIA CONTACT US Optimal Go-to-Market Strategy We are on a mission to…
Conception combines stem cell biology and engineering to create new possibilities for having children.
News
Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation
CHICAGO & MILPITAS, Calif., June 23, 2026--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome engineering, tod
Read more
Report
Report
Syntax Bio Raises $14.4 Million Series A And Announces Leadership Appointments
Syntax Bio announced an expanded Series A round and several leadership appointments across its executive team, board of directors, and scientific advisory board. The expanded round brings Syntax Bio's Series A to $14.4 million and total funding to more th
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Financials
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2026 | — | Details |